These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 25921053)

  • 1. Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
    Shimizu Y; Fujihara K; Ohashi T; Nakashima I; Yokoyama K; Ikeguch R; Takahashi T; Misu T; Shimizu S; Aoki M; Kitagawa K
    Mult Scler; 2016 Oct; 22(11):1413-1420. PubMed ID: 25921053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder.
    Collongues N; Alves Do Rego C; Bourre B; Biotti D; Marignier R; da Silva AM; Santos E; Maillart E; Papeix C; Palace J; Leite MIS; De Seze J
    Neurology; 2021 Apr; 96(15):e2006-e2015. PubMed ID: 33627499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-Related Attack in Neuromyelitis Optica Spectrum Disorder With AQP4-IgG: A Single-Center Study and Meta-Analysis.
    Deng S; Lei Q; Lu W
    Front Immunol; 2021; 12():800666. PubMed ID: 35069584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
    Montcuquet A; Collongues N; Papeix C; Zephir H; Audoin B; Laplaud D; Bourre B; Brochet B; Camdessanche JP; Labauge P; Moreau T; Brassat D; Stankoff B; de Seze J; Vukusic S; Marignier R;
    Mult Scler; 2017 Sep; 23(10):1377-1384. PubMed ID: 27885065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases.
    Lin J; Xue B; Li J; Xie D; Weng Y; Zhang X; Li X; Xia J
    Front Immunol; 2024; 15():1406409. PubMed ID: 38994358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between severe attacks and serum aquaporin-4 antibody titer in neuromyelitis optica spectrum disorder.
    Wang R; Sun D; Wang X; Shi Z; Kong L; Du Q; Zhang Y; Chen H; Luo W; Zhang N; Zhou H
    J Neurol; 2024 Jul; 271(7):4503-4512. PubMed ID: 38703259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review.
    Siriratnam P; Huda S; Butzkueven H; van der Walt A; Jokubaitis V; Monif M
    Autoimmun Rev; 2024 Feb; 23(2):103499. PubMed ID: 38061621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk of postpartum relapses in neuromyelitis optica spectrum disorder.
    Klawiter EC; Bove R; Elsone L; Alvarez E; Borisow N; Cortez M; Mateen F; Mealy MA; Sorum J; Mutch K; Tobyne SM; Ruprecht K; Buckle G; Levy M; Wingerchuk D; Paul F; Cross AH; Jacobs A; Chitnis T; Weinshenker B
    Neurology; 2017 Nov; 89(22):2238-2244. PubMed ID: 29093070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of pregnancy on neuromyelitis optica spectrum disorders and multiple sclerosis.
    Tong Y; Liu J; Yang T; Kang Y; Wang J; Zhao T; Cheng C; Fan Y
    Mult Scler Relat Disord; 2018 Oct; 25():61-65. PubMed ID: 30048918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.
    Kim SM; Waters P; Woodhall M; Kim YJ; Kim JA; Cheon SY; Lee S; Jo SR; Kim DG; Jung KC; Lee KW; Sung JJ; Park KS
    Mult Scler; 2017 Jul; 23(8):1104-1111. PubMed ID: 27760862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
    Nour MM; Nakashima I; Coutinho E; Woodhall M; Sousa F; Revis J; Takai Y; George J; Kitley J; Santos ME; Nour JM; Cheng F; Kuroda H; Misu T; Martins-da-Silva A; DeLuca GC; Vincent A; Palace J; Waters P; Fujihara K; Leite MI
    Neurology; 2016 Jan; 86(1):79-87. PubMed ID: 26581304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
    Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
    Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
    Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies.
    Kim SH; Jang H; Park NY; Kim Y; Kim SY; Lee MY; Hyun JW; Kim HJ
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33622675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies.
    Wang L; Tan H; Huang W; Chang X; ZhangBao J; Zhou L; Lu C; Wang M; Lu J; Zhao C; Quan C
    Eur J Neurol; 2022 Apr; 29(4):1128-1135. PubMed ID: 34967093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China.
    Huang Y; Wang Y; Zhou Y; Huang Q; Sun X; Chen C; Fang L; Long Y; Yang H; Wang H; Li C; Lu Z; Hu X; Kermode AG; Qiu W
    J Neurol Sci; 2017 Jan; 372():152-156. PubMed ID: 28017203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
    Ringelstein M; Harmel J; Distelmaier F; Ingwersen J; Menge T; Hellwig K; Kieseier B; Mayatepek E; Hartung HP; Kuempfel T; Aktas O
    Mult Scler; 2013 Oct; 19(11):1544-7. PubMed ID: 23886825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.